Position in AKBA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$69,408
-$10,985 QoQ
Shares Held
49,934
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SEI INVESTMENTS CO holds $465,169,226 across 39 Drug Manufacturers - Specialty & Generic names. AKBA ranks #37 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
5,650,393 | $135,213,903 | |
| 2 | ZTS |
Zoetis Inc.
|
667,165 | $78,865,573 | |
| 3 | VTRS |
Viatris Inc
|
3,720,915 | $50,269,560 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,182,751 | $35,624,459 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
235,251 | $30,991,966 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
28,421 | $16,853,083 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
284,005 | $13,674,840 | |
| 8 | HLN |
Haleon plc
|
1,285,485 | $12,867,704 |
All Filings in AKBA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $69,408 | 49,934 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $80,393 | 49,934 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $154,245 | 56,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $696,131 | 191,245 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $336,086 | 175,045 | Shares | Defined | 2025-05-14 | |
| 2020-12-31 | $39,846 | 14,231 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $39,245 | 15,636 | Shares | Sole | 2020-12-04 | |
| 2020-06-30 | $676,500 | 49,816 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $99,214 | 13,089 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||